Physician

James R. Reid, M.D.

According to 2025 Medicare claims, James Reid, M.D. (NPI: 1710911193) practices family practice in the Staunton-Stuarts Draft, VA market, with the plurality of this provider's patient population coming from Waynesboro City, VA. This provider's primary affiliated billing organization is UNIVERSITY OF VIRGINIA PHYSICIANS GROUP (NPI: 1033138250; TIN: 541124769) and primary practice location at 22980-3237. Reid is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Reid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 568 traditional Medicare patients, billed 3,213 HCPCS/CPT codes, and received $174,780 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 16,305 prescription claims across 1,082 beneficiaries totaling $1,348,961 in drug costs, led by Ozempic (Semaglutide). DME data shows 250 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $842,324 to $1,348,961. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $25,471 and ending at $22,575.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	572	3,261	$170,553
2016	566	3,426	$179,350
2017	603	3,570	$176,098
2018	586	3,586	$187,736
2019	584	3,246	$170,014
2020	539	2,843	$143,057
2021	712	3,667	$213,117
2022	702	3,735	$203,710
2023	631	3,409	$193,952
2024	568	3,213	$174,780

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	718	11,405	$842,324
2016	734	11,909	$865,215
2017	846	13,404	$1,001,905
2018	773	12,289	$940,513
2019	735	11,212	$928,183
2020	727	10,869	$806,851
2021	1,092	13,160	$1,042,477
2022	1,192	14,689	$1,293,027
2023	1,124	16,075	$1,702,363
2024	1,082	16,305	$1,348,961

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	118	551	$22,536
2016	126	827	$31,398
2017	101	638	$12,614
2018	133	650	$12,927
2019	86	485	$11,959
2020	68	384	$11,555
2021	45	233	$7,974
2022	40	257	$11,387
2023	38	249	$10,954
2024	41	250	$18,203

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	395	395	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	494	980	$80
90673	Influenza vaccine, trivalent derived from recombinant dna	102	102	$62
G0008	Administration of influenza virus vaccine	102	103	$21
36415	Insertion of needle into vein for collection of blood sample	381	489	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	155	6,476	$208,223
Eliquis	Apixaban	220	10,860	$207,173
Trulicity	Dulaglutide	121	4,902	$164,791
Jardiance	Empagliflozin	113	5,190	$101,135
Mounjaro	Tirzepatide	27	1,036	$38,356

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	34	$13,507
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	32	$2,493
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	28	75	$1,033
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	20	$517
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$204

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for James R. Reid, M.D.?

Tedicare shows public-source Medicare data for James R. Reid, M.D. (NPI 1710911193), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James R. Reid, M.D. have ACO affiliation data?

James R. Reid, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to James R. Reid, M.D.?

James R. Reid, M.D. is linked to UNIVERSITY OF VIRGINIA PHYSICIANS GROUP (billing NPI 1033138250) in the available physician profile data.

Does James R. Reid, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.